计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
GSK269962A HCl (GSK269962B, GSK269962) is a selectiveROCK(Rho-associated protein kinase)inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
Targets
ROCK1 (Cell-free assay); ROCK2 (Cell-free assay); MSK1 (Cell-free assay); RSK1 (Cell-free assay) 1.6 nM ;4 nM; 49 nM; 132 nM
In vitro
GSK269962A completely abolished the actin stress fiber formation induced by angiotensin II in human smooth muscles. Such suppressive effect on actin fiber formation was observed beginning at around 1 μM GSK269962A. GSK269962A induced vasorelaxation in preconstricted rat aorta(tissue baths) with an IC50 of 35 nM. the relaxation induced by GSK269962A is reversible. GSK269962A suppressed IL-6 mRNA transcription and reduced LPS-induced IL-6 and TNF-α protein production in macrophages.
In vivo
Oral administration of GSK269962A produced a profound dose-dependent reduction of systemic blood pressure in spontaneously hypertensive rats. The reduction of blood pressure was acute and substantial. The maximal effect on blood pressure was observed approximately 2 h after oral gavages. The reduction of blood pressure was accompanied by an acute, dose-dependent increase in heart rate, presumably due to the activation of baroreflex mechanism. ROCK inhibition with the use of GSK 269962 in the 10 mg/kg dose, in turn, triggered an increase in VV(voided volume), PVR(post-void residual), VT(volume threshold), VE(voiding efficiency), ICI(intercontraction interval), BC(bladder compliance), and VTNVC(volume threshold to elicit NVC). The inhibition of the ROCK pathway through GSK 269962 appeared to have no effect on either HR(heart rate), SBP(systolic blood pressure), MBP(systolic blood pressure), or DBP(diastolic blood pressure). NVC:nonvoiding contractions.
Cell Research(from reference)
Cell lines:Human primary smooth muscle cells
Concentrations:3 μM
Incubation Time:150 min
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 苯胺类 |
| 中间层级节点(Intermediate Tree Nodes) | 芳香族苯胺 |
| 直接上位类(Direct Parent) | 苯甲酰苯胺类 |
| 其他上位类(Alternative Parents) | 二芳醚 苯甲酰胺类 咪唑并[4,5-c]吡啶 苯氧基化合物 酚醚 苯甲酰衍生物 烷基芳基醚 吡啶及其衍生物 N-取代咪唑 吗啉 咪唑内酰胺类 杂芳族化合物 弗拉赞 三烷基胺 仲羧酸酰胺 氨基酸及其衍生物 氧环化合物 氮杂环化合物 二烷基醚 有机氧化物 盐酸盐 伯胺 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 芳基醚 - 氨基酸 - 氨基酸或其衍生物 - 芳香族杂多环化合物 - 氮杂环 - 吡唑 - 苯甲酰胺 - 苯甲酰胺 - 苯甲酸或衍生物 - 苯甲酰 - 羧酰胺基 - 羧酸衍生物 - 二烷基醚 - 二芳基醚 - 乙醚 - 呋喃嗪 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 吡啶-4,5-二甲酰胺 - 咪唑 - 咪唑吡啶酮 - 咪唑内酰胺 - Morpholine - N-取代咪唑 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 氧杂噁唑 - 氧杂吡嗪烷 - 苯酚醚 - 苯氧基化合物 - 初级胺 - 吡啶 - 醛基 - 三元脂肪胺 - 三芳基胺 |
| 描述(Description) | 该化合物属于苯甲酰胺类有机化合物。这类芳香化合物含有酰胺基团,其中羧酰胺基被苯环取代。其通式为RNC(=O)R',其中R、R'=苯环。 |
| 外部描述符(External Descriptors) | 暂无 |
| IC50 | ROCK2, IC50: 4 nM |
|---|---|
| ALogP | 3.776 |
| hba_count | 9 |
| HBD Count | 2 |
| Rotatable Bond | 10 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|